Post-hoc Estimation of a Quantitative Restriction Spectrum Imaging Biomarker for Prostate Cancer Detection Using Conventional MRI
Do, D.; Conlin, C. C.; Bagrodia, A.; Cooperberg, M.; Hahn, M. E.; Harisinghani, M.; Hollenberg, G.; Javier-Desloges, J.; Kamran, S.; Kane, C. J.; Lee, K.-L.; Liss, M. A.; Margolis, D. J.; Murphy, P.; Nakrour, N.; Ohliger, M.; Osinski, T.; Rakow-Penner, R.; Rojo Domingo, M.; Salmasi, A.; Shabaik, A.; Song, Y.; Trecarten, S.; Wehrli, N.; Weinberg, E.; Woolen, S.; Dale, A. M.; Seibert, T. M.
Show abstract
BackgroundMultiparametric MRI is useful for early detection of clinically significant prostate cancer (csPCa), but its standard Apparent Diffusion Coefficient (ADC) has limited utility as a quantitative metric for automated, patient-level detection of csPCa. Restriction Spectrum Imaging (RSI), an advanced diffusion technique, yields a quantitative biomarker (RSIrs) that improves csPCa detection. RSIrs is typically calculated from a dedicated multi-b-value acquisition. RSIrs estimated from conventional MRI has not been studied. PurposeTo evaluate the accuracy and validity of RSI metrics estimated post-hoc from conventional diffusion-weighted imaging (DWI) to serve as a viable surrogate for a dedicated RSI acquisition. Materials and MethodsWe conducted a retrospective, multi-center study of patients with both a dedicated RSI acquisition and conventional DWI. We compared three different RSI restriction score (RSIrs) calculation methods: from the dedicated acquisition (RSIrsdedicated), from conventional DWI alone (RSIrspost-hoc), and from a combination of conventional DWI with only the high b-values from the RSI acquisition (RSIrscombo). We compared these methods for quantitative agreement and csPCa detection performance (Area under the Receiver Operating Characteristic [AUC, 95% Confidence Interval]) of maximum RSIrs (RSIrsmax) in the prostate compared to that of minimum ADC (ADC). ResultsData from n=1095 patients (16 centers) were analyzed. Post-hoc RSIrsmax differed systematically from RSIrsdedicated by a median of +156 (RSIrspost-hoc) and -59 (RSIrscombo), respectively. AUCs for csPCa detection were 0.51 [0.47,0.54], 0.60 [0.57,0.64], 0.70 [0.67,0.74], and 0.77 [0.74,0.80] for ADC, RSIrspost-hoc, RSIrscombo, and RSIrsdedicated, respectively. ConclusionEven when estimated using conventional DWI, RSIrs is a superior quantitative biomarker to ADC for automated, patient-level detection of csPCa. A dedicated RSI acquisition gives the best performance. A compromise would be to acquire high b-values (1500 s/mm2, 2500 s/mm2) to complement low b-values (<1000 s/mm2) from conventional DWI.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.